Name: Early Diagnostics of Articular Syndrome in Reactive Arthritis (en Inglés)
SKU: 59036055
Price: 277536.00 COP
Availability: InStock
Author: Khalmetova, Feruza ; Akhmedov, Khalmurad ; Rakhimov, Sardorbek
ISBN: 9786206163442

portada Early Diagnostics of Articular Syndrome in Reactive Arthritis (en Inglés)

Early Diagnostics of Articular Syndrome in Reactive Arthritis (en Inglés)

Formato

Libro Físico

Autor

Feruza Khalmetova

Khalmurad Akhmedov

Sardorbek Rakhimov

Editorial

LAP Lambert Academic Publishing

Idioma

Inglés

N° páginas

128

Encuadernación

Tapa Blanda

Dimensiones

22.9x15.2x0.8 cm

Peso

0.20 kg.

ISBN13

9786206163442

Categorías

Música

Early Diagnostics of Articular Syndrome in Reactive Arthritis (en Inglés)

Feruza Khalmetova (Autor) · Khalmurad Akhmedov (Autor) · Sardorbek Rakhimov (Autor) · LAP Lambert Academic Publishing · Tapa Blanda

Libro Nuevo Importado

Envío: 20 a 24 días háb.

$ 462.560$ 277.536

-40%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 277.536

¡Envío Gratis! Llega entre el 03 Dic y el 11 Dic a Bogota, Cundinamarca. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Early Diagnostics of Articular Syndrome in Reactive Arthritis (en Inglés)"

In many countries of the world, among chronic inflammatory diseases of the joints, morbidity and disability rates due to reactive arthritis are increasing. In the research of a number of scientists, a doubling of the incidence of reactive arthritis has been observed over the last thirty years, and the incidence rate among the population of different countries is 0.2%-0.68%. In developed countries, the average age of reactive arthritis patients is 35 years, and the percentage of women among patients has increased by 30%. According to the opinions formed in recent years, the pathogenesis of reactive arthritis is based on immunological disturbances, and in 88-96% of cases, an inadequate cytostatic immunological response to the HLA-B27-antigen. Although ideas about its etiopathogenetic mechanisms have been created, the different nature of the joint syndrome causes scientists to form different, sometimes contradictory opinions. The main goal of such therapy is to reduce the main symptoms of the joint syndrome, while protecting against damage expected in the structure of the ankle tissue during the progression of arthrosis.